News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,300 Results
Type
Article (62197)
Company Profile (464)
Press Release (663639)
Multimedia
Podcasts (108)
Webinars (13)
Section
Business (195773)
Career Advice (3500)
Deals (35383)
Drug Delivery (126)
Drug Development (85171)
Employer Resources (179)
FDA (17393)
Job Trends (15499)
News (343927)
Policy (34853)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (9)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (10)
2024 Pharm Country Digital (9)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2927)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (51516)
ALS (97)
Alzheimer's disease (1488)
Antibody-drug conjugate (ADC) (151)
Approvals (17362)
Artificial intelligence (285)
Autoimmune disease (28)
Automation (16)
Bankruptcy (357)
Best Places to Work (12229)
BIOSECURE Act (21)
Biosimilars (116)
Biotechnology (350)
Bladder cancer (84)
Brain cancer (32)
Breast cancer (297)
Cancer (2393)
Cardiovascular disease (199)
Career advice (2964)
Career pathing (34)
CAR-T (171)
Cell therapy (481)
Cervical cancer (20)
Clinical research (68883)
Collaboration (900)
Compensation (521)
Complete response letters (28)
COVID-19 (2783)
CRISPR (46)
C-suite (259)
Cystic fibrosis (106)
Data (2235)
Decentralized trials (2)
Denatured (36)
Depression (52)
Diabetes (292)
Diagnostics (6525)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (135)
Drug pricing (123)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (75182)
Editorial (43)
Employer branding (23)
Employer resources (155)
Events (115268)
Executive appointments (753)
FDA (18675)
Featured Employer (58)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (798)
Gene editing (117)
Generative AI (29)
Gene therapy (354)
GLP-1 (827)
Government (4895)
Grass and pollen (6)
Guidances (54)
Healthcare (20058)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (141)
Indications (30)
Infectious disease (2939)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (101)
Interviews (687)
IPO (16546)
IRA (49)
Job creations (3755)
Job search strategy (2414)
Kidney cancer (11)
Labor market (36)
Layoffs (506)
Leadership (23)
Legal (7992)
Liver cancer (81)
Lung cancer (341)
Lymphoma (157)
Machine learning (7)
Management (62)
Manufacturing (337)
MASH (74)
Medical device (13613)
Medtech (13617)
Mergers & acquisitions (19407)
Metabolic disorders (769)
Multiple sclerosis (85)
NASH (23)
Neurodegenerative disease (113)
Neuropsychiatric disorders (34)
Neuroscience (2080)
NextGen: Class of 2025 (7184)
Non-profit (4886)
Northern California (2658)
Now hiring (34)
Obesity (417)
Opinion (273)
Ovarian cancer (77)
Pain (95)
Pancreatic cancer (84)
Parkinson's disease (160)
Partnered (22)
Patents (242)
Patient recruitment (112)
Peanut (51)
People (57259)
Pharmaceutical (92)
Pharmacy benefit managers (20)
Phase I (21429)
Phase II (30224)
Phase III (22693)
Pipeline (1218)
Policy (164)
Postmarket research (2795)
Preclinical (9311)
Press Release (69)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (428)
Real estate (6002)
Recruiting (72)
Regulatory (24219)
Reports (37)
Research institute (2595)
Resumes & cover letters (565)
Rett syndrome (5)
RNA editing (5)
RSV (47)
Schizophrenia (79)
Series A (139)
Series B (90)
Service/supplier (11)
Sickle cell disease (58)
Southern California (2311)
Special edition (18)
Spinal muscular atrophy (163)
Sponsored (34)
Startups (3725)
State (2)
Stomach cancer (16)
Supply chain (72)
Tariffs (43)
The Weekly (70)
United States (23673)
Vaccines (781)
Venture capitalists (43)
Weight loss (293)
Women's health (35)
Worklife (19)
Date
Today (218)
Last 7 days (922)
Last 30 days (2807)
Last 365 days (34485)
2025 (11008)
2024 (36863)
2023 (41472)
2022 (52683)
2021 (57296)
2020 (55909)
2019 (49201)
2018 (37325)
2017 (34532)
2016 (34400)
2015 (39512)
2014 (32436)
2013 (27959)
2012 (29566)
2011 (29960)
2010 (28316)
Location
Africa (1022)
Alabama (55)
Alaska (7)
Arizona (205)
Arkansas (14)
Asia (43337)
Australia (7450)
California (6169)
Canada (2010)
China (545)
Colorado (272)
Connecticut (289)
Delaware (148)
Europe (98743)
Florida (913)
Georgia (201)
Idaho (61)
Illinois (591)
India (27)
Indiana (313)
Iowa (12)
Japan (161)
Kansas (105)
Kentucky (26)
Louisiana (13)
Maine (70)
Maryland (908)
Massachusetts (4781)
Michigan (224)
Minnesota (392)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (64)
New Hampshire (68)
New Jersey (1765)
New Mexico (30)
New York (1766)
North Carolina (1073)
North Dakota (9)
Northern California (2658)
Ohio (209)
Oklahoma (14)
Oregon (37)
Pennsylvania (1392)
Puerto Rico (13)
Rhode Island (32)
South America (1353)
South Carolina (22)
South Dakota (1)
Southern California (2311)
Tennessee (96)
Texas (910)
Utah (183)
Virginia (156)
Washington D.C. (64)
Washington State (580)
West Virginia (3)
Wisconsin (56)
726,300 Results for "the alliance for regenerative medicine arm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector
Veristat, the Science-First Full Service CRO and Consultancy, announced it has joined the Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of cell and gene therapies for patients, healthcare systems, and society.
April 3, 2024
·
3 min read
Press Releases
Joseph Spine Institute Launches Center for Regenerative Spine Medicine, Pioneering Advanced Stem Cell Therapy
April 10, 2025
·
2 min read
Press Releases
Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.
January 2, 2025
·
6 min read
Press Releases
Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
September 27, 2024
·
8 min read
Business
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. and Minaris Regenerative Medicine Co., today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
June 20, 2024
·
6 min read
Press Releases
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
April 16, 2025
·
4 min read
Press Releases
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
April 15, 2025
·
8 min read
Press Releases
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
April 14, 2025
·
7 min read
Gene therapy
Patient Death in Rett Syndrome Trial Forces Neurogene to Drop High-Dose Arm
Despite the death, the FDA has allowed Neurogene to forge ahead with the Phase I/II Rett syndrome trial, but using only the lower 1E15 vg dose of its investigational gene therapy NGN-401.
November 22, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
February 3, 2025
·
8 min read
1 of 72,630
Next
